Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blood Test for Breast Cancer Associated Auto Antibodies - Improvement of Octava Blood Test

NCT02066025 is registered in ClinicalTrials.gov with Eventus Diagnostics Ltd as lead sponsor.

NCT NCT02066025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02066025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blood Test for Breast Cancer Associated Auto Antibodies - Improvement of Octava Blood Test
Lead sponsor
Eventus Diagnostics Ltd
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2014
Completion date
March 31, 2018
Enrollment
1,425 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer